Figure 7 — Development a m6A regulators characterized by the immune cell infiltration in stomach adenocarcinoma for predicting the prognosis and immunotherapy response

Research Paper|Volume 15, Issue 6|pp. 1944–1963

Development a m⁶A regulators characterized by the immune cell infiltration in stomach adenocarcinoma for predicting the prognosis and immunotherapy response

Back to articleFigure 7(7 of 8)

100%

Figure 7.The m⁶A score predicts immunotherapeutic benefits. (A–D) TCIA database-based correlations of m⁶A score with IPS among the PAAD patients: (A) CTLA4(−) PD1(−) (B) CTLA4(−) PD1(+) (C) CTLA4(+) PD1(−) (D) CTLA4(+) PD1(+). (E) Distribution of m⁶A score in different MSI groups. (F) The ratio of MSI (microsatellite instability) in STAD samples with MSS and MSI-L and MSI-H.